| [1] |
Haris A，Dolgos S，Polner K.Therapy and prognosis of ANCA-associated vasculitis from the clinical nephrologist′s perspective[J].Int Urol Nephrol，2017，49（1）：91-102.
|
| [2] |
Kain R，Exner M，Brandes R，et al.Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis[J].Nature Med，2008，14（10）：1088-1096.
|
| [3] |
Kim YC，Choi YS，Alam J，et al.Induction of proteinase 3-anti-neutrophil cytoplasmic autoantibodies by proteinase 3-homologous bacterial protease in mice[J].Immunologic Res，2016，64（2）：438-444.
|
| [4] |
Yang J，Bautz DJ，Lionaki S，et al.ANCA patients have T cells responsive to complementary PR-3 antigen[J].Kidney Int，2008，74（9）：1159-1169.
|
| [5] |
Reynolds J，Preston GA，Pressler BM，et al.Autoimmunity to the alpha 3 chain of typeⅣcollagen in glomerulonephritis is triggered by autoantigen complementarity[J].J Autoimmun，2015，59：8-18.
|
| [6] |
Soderberg D，Segelmark M.Neutrophil extracellular traps in ANCA-associated vasculitis[J].Frontiers Immunol，2016，7（21）：256-264.
|
| [7] |
Nakazawa D，Shida H，Tomaru U，et al.Enhanced formation and disordered regulation of NETs in myeloperoxidase-ANCA-associated microscopic polyangiitis[J].J Am Soc Nephrol，2014，25（5）：990-997.
|
| [8] |
Lyons PA，Rayner TF，Trivedi S，et al.Genetically distinct subsetswithinANCA-associated vasculitis[J].New Engl J Med，2012，367（3）：214-223.
|
| [9] |
Xie G，Roshandel D，Sherva R，et al.Association of granulomatosis with polyangiitis（Wegener′s）with HLA-DPB1 04 and SEMA6A gene variants：evidence from genome-wide analysis[J].Arthritis Rheum，2013，65：2457-2468.
|
| [10] |
Ciavatta DJ，Yang J，Preston GA，et al.Epigenetic basis for aberrant upregulation of autoantigen genes in humans with ANCA vasculitis[J].J Clin Invest，2010，120（9）：3209-3219.
|
| [11] |
Chen M，Jayne DRW，Zhao MH.Complement in ANCA-associated vasculitis：mechanisms and implications for management[J].Nature Rev Nephrol，2017，13（6）：359-367.
|
| [12] |
Xiao H，Dairaghi DJ，Powers JP，et al.C5a receptor（CD88）blockade protects against MPO-ANCA GN[J].J Am Soc Nephrol，2014，25（2）：225-231.
|
| [13] |
Schreiber A，Xiao H，Jennette JC，et al.C5a receptor mediates neutrophil activation and ANCA-induced glomerulonephritis[J].J Am Soc Nephrol，2009，20（2）：289-298.
|
| [14] |
Hao J，Wang C，Yuan J，et al.A pro-inflammatory role of C5L2 in C5a-primed neutrophils for ANCA-induced activation[J].PLoS One，2013，8（6）：1-9.
|
| [15] |
Wang H，Wang C，Zhao MH，et al.Neutrophil extracellular traps can activate alternative complement pathways[J].Clin Exp Immunol，2015，181（3）：518-527.
|
| [16] |
Ruth AJ，Kitching AR，Kwan RY，et al.Anti-neutrophil cytoplasmic antibodies and effector CD4+cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis[J].J Am Soc Nephrol，2006，17（7）：1940-1949.
|
| [17] |
Nogueira E，Hamour S，Sawant D，et al.Serum IL-17 and IL-23 levels and autoantigen-specific Th17 cells are elevated in patients with ANCA-associated vasculitis[J].Nephrol Dial Transplant，2010，25（7）：2209-2217.
|
| [18] |
Ghali JR，Wang YM，Holdsworth SR，et al.Regulatory T cells in immune-mediated renal disease[J].Nephrology，2016，21（2）：86-96.
|
| [19] |
Gan PY，Tan DS，Ooi JD，et al.Myeloperoxidase peptidebased nasal tolerance in experimental ANCA-associated GN[J].J Am Soc Nephrol，2016，27（2）：385-391.
|
